NEW YORK, July 6, 2017 /PRNewswire/ --

Elsevier, the information analytics company specializing in science and health, today announced the 45 finalists for the 2017 Reaxys PhD Prize. Selected from nearly 550 submissions from around the globe, these 45 talented chemists are invited to the Prize Symposium that will be held on October 19 and 20, 2017, in Shanghai.

Launched in 2010, the Reaxys PhD Prize celebrates chemistry PhD students and recent graduates, fostering creativity in ground-breaking chemistry. Besides identifying tomorrow's chemistry leaders, the Prize seeks to empower them to magnify the impact of their work. This starts with the Prize Symposium, where the finalists are provided with an international stage for presenting their research and the opportunity to extend their network with their fellow finalists and internationally recognized chemists.

The 2017 Reaxys PhD Prize Symposium is also the occasion for the Reaxys Advisory Board and Prize coordinators to select the three winners, based on the originality, innovation, relevance and methodological rigor of their presented work. The winners will be announced at the banquet following the Symposium.

The selection of the winners is the last step of a long and rigorous review process. Started in March, the process involved more than 100 international chemists from academia and industry, who, together with Prize Coordinators, are the key to ensure a fair and rigorous selection process.

"As one of the Prize coordinators since 2010, I am very proud to see the continued developed of the Prize. The quality of the submissions is fantastic," said Prof Henry N. C. Wong of the Chinese University of Hong Kong. "I know we will have another difficult but exciting discussion in order to identify this year's winners. I am looking forward to the Symposium in Shanghai and to meeting the finalists in person. Their enthusiasm for their research and for chemistry is one of the most rewarding aspects of the meeting."

This year's 45 finalists are:

• Ahmed Badran from the Liu group, Harvard University
• Joshua Barham from the Murphy group, University of Strathclyde
• Suzanne Batiste from the Johnston group, Vanderbilt University
• Antonio Bauzá from the Frontera group, University of Balearic Islands
• Charlotte Boott from the Pringle group, University of Bristol
• Anna Brezny from the Landis group, University of Wisconsin - Madison
• Lumen Chao from the Murata group, Kyoto University
• Zhe Dong from the Dong group, University of Chicago
• Brendan  Fallon from the Petit group, University Pierre & Marie Curie
• Alexander Giovannitti from the McCulloch group, Imperial College London
• Robert Heinze from the Heretsch group, Freie University of Berlin
• Yoshihiko Iwane from the Suga group, University of Tokyo
• Xingxing Jiang from the Lin group, University of Chinese Academy of Science
• Jonathan Kuo from the Norton group, Columbia University
• Shogo Kuriyama from the Nishibayashi group, University of Tokyo
• Hiu Lam from the George group, University of Adelaide
• Matthew Landry from the Burns group, Stanford University
• Mark Levin from the Toste group, University of California Berkeley
• Kuangbiao Liao from the Davies group, Emory University
• Maria Cristina Lo Giudice from the  Dawson group, University College Dublin
• Moritz Malischewski from the Seppelt group, Freie University of Berlin
• Koichi Nagata from the Tokitoh group, Kyoto University
• Takayuki Nakamuro from the Murakami group, Kyoto University
• Ryo Nakano from the Nozaki group, University of Tokyo
• Dennis Nielsen from the Skrydstrup group, Aarhus University
• Keisuke Nogi from the Tsuji group, Kyoto University
• Jennifer Obligacion from the Chirik group, Princeton University
• Thomas Osberger from the White group, University of Illinois at Urbana-Champaign
• Harshkumar Patel from the Sigman group, University of Utah
• Aleksandra Pekosak from the Windhorst group, Vrije University Medical Center Amsterdam
• Catherine Pitman from the Miller group, University of North Carolina at Chapel Hill
• Derrick Roberts from the Nitschke group, University of Cambridge
• Jessica Rodriguez Villar from the Mascareñas group, University of Santiago de Compostela
• Koki Sano from the Aida group, University of Tokyo
• Ryan Schwamm from the Coles group, Victoria University of Wellington
• Sergii Shylin from the Ksenofontov group, Johannes Gutenberg University of Mainz
• Markus Suta from the Wickleder group, University of Siegen
• Andy Thomas from the Denmark group, University of Illinois at Urbana-Champaign
• Veaceslav Vieru from the Chibotaru group, KU Leuven
• Fei Wang from the Guosheng Liu group, Shanghai Institute of Organic Chemistry Chinese Academy of Sciences
• Min Wang from the Wen Liu group, Shanghai Institute of Organic Chemistry Chinese Academy of Sciences
• Miles White from the Vela group, Iowa State University
• Kumiko Yamamoto from the Kanai group, University of Tokyo
• Sui Yang from the Zhang group, University of California Berkeley
• Changchun Yuan from the Liu group, Sichuan University

Find out more about the Reaxys PhD Prize and Symposium.

Reaxys is a trademark of RELX Intellectual Properties SA, used under license.

About Elsevier  

Elsevier is a global information analytics company that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. http://www.elsevier.com

Media contact
Christopher Capot
Global Communications, Elsevier
+1-917-704-5174
c.capot@elsevier.com

SOURCE Elsevier